Arteriosclerosis, Vol 10, 497-511, Copyright © 1990 by American Heart Association
ARTICLES |
JP Despres, S Moorjani, PJ Lupien, A Tremblay, A Nadeau and C Bouchard
Physical Activity Sciences Laboratory, Laval University, Ste-Foy, Quebec, Canada.
Several epidemiological studies have reported that the regional distribution of body fat is a significant and independent risk factor for cardiovascular disease (CVD) and related mortality. Although these associations are well established, the causal mechanisms are not fully understood. Numerous studies have, however, shown that specific topographic features of adipose tissue are associated with metabolic complications that are considered as risk factors for CVD such as insulin resistance, hyperinsulinemia, glucose intolerance and type II diabetes mellitus, hypertension, and changes in the concentration of plasma lipids and lipoproteins. The present article summarizes the evidence on the metabolic correlates of body fat distribution. Potential mechanisms for the association between body fat distribution, metabolic complications, and CVD are reviewed, with an emphasis on plasma lipoprotein levels and plasma lipid transport. From the evidence available, it seems likely that subjects with visceral obesity represent the subgroup of obese individuals with the highest risk for CVD. Although body fat distribution is now considered as a more significant risk factor for CVD and related death rate than obesity per se, further research is clearly needed to identify the determinants of body fat distribution and the causal mechanisms involved in the metabolic alterations. It appears certain, however, that an altered plasma lipid transport is a significant component of the relation between body fat distribution and CVD.
This article has been cited by other articles:
![]() |
R. Ness-Abramof and C. M. Apovian Waist Circumference Measurement in Clinical Practice Nutr Clin Pract, August 1, 2008; 23(4): 397 - 404. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Staruchova, A. R. Collins, K. Volkovova, C. Mislanova, Z. Kovacikova, J. Tulinska, A. Kocan, L. Staruch, L. Wsolova, and M. Dusinska Occupational exposure to mineral fibres. Biomarkers of oxidative damage and antioxidant defence and associations with DNA damage and repair Mutagenesis, July 1, 2008; 23(4): 249 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Despres, I. Lemieux, J. Bergeron, P. Pibarot, P. Mathieu, E. Larose, J. Rodes-Cabau, O. F. Bertrand, and P. Poirier Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk Arterioscler. Thromb. Vasc. Biol., June 1, 2008; 28(6): 1039 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. E. Hirai, S. E. Moss, B. E.K. Klein, and R. Klein Relationship of Glycemic Control, Exogenous Insulin, and C-Peptide Levels to Ischemic Heart Disease Mortality Over a 16-Year Period in People With Older-Onset Diabetes: The Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR) Diabetes Care, March 1, 2008; 31(3): 493 - 497. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Despres, P. Poirier, J. Bergeron, A. Tremblay, I. Lemieux, and N. Almeras From individual risk factors and the metabolic syndrome to global cardiometabolic risk Eur. Heart J. Suppl., March 1, 2008; 10(suppl_B): B24 - B33. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hollander Cardiometabolic Risk Factors and Visceral Adipose Tissue The Diabetes Educator, March 1, 2008; 34(Supplement_2): 37S - 41S. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Balkau, J. E. Deanfield, J.-P. Despres, J.-P. Bassand, K. A.A. Fox, S. C. Smith Jr, P. Barter, C.-E. Tan, L. Van Gaal, H.-U. Wittchen, et al. International Day for the Evaluation of Abdominal Obesity (IDEA): A Study of Waist Circumference, Cardiovascular Disease, and Diabetes Mellitus in 168 000 Primary Care Patients in 63 Countries Circulation, October 23, 2007; 116(17): 1942 - 1951. [Abstract] [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, I. Graham, D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cifkova, J. Dallongeville, G. De Backer, S. Ebrahim, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts) Eur. Heart J., October 1, 2007; 28(19): 2375 - 2414. [Full Text] [PDF] |
||||
![]() |
M. W Peeters, G. P Beunen, H. H Maes, R. J. Loos, A. L Claessens, R. Vlietinck, and M. A Thomis Genetic and environmental determination of tracking in subcutaneous fat distribution during adolescence Am. J. Clinical Nutrition, September 1, 2007; 86(3): 652 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Balkau, P. Picard, S. Vol, L. Fezeu, E. Eschwege, and for the DESIR Study Group Consequences of Change in Waist Circumference on Cardiometabolic Risk Factors Over 9 Years: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) Diabetes Care, July 1, 2007; 30(7): 1901 - 1903. [Full Text] [PDF] |
||||
![]() |
K. Azuma, L. K. Heilbronn, J. B. Albu, S. R. Smith, E. Ravussin, D. E. Kelley, and and the Look AHEAD Adipose Research Group Adipose tissue distribution in relation to insulin resistance in type 2 diabetes mellitus Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E435 - E442. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Vazquez, S. Duval, D. R. Jacobs Jr., and K. Silventoinen Comparison of Body Mass Index, Waist Circumference, and Waist/Hip Ratio in Predicting Incident Diabetes: A Meta-Analysis Epidemiol. Rev., May 10, 2007; (2007) mxm008v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. de Koning, A. T. Merchant, J. Pogue, and S. S. Anand Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies Eur. Heart J., April 2, 2007; (2007) ehm026v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fontana, J. C. Eagon, M. E. Trujillo, P. E. Scherer, and S. Klein Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese Humans Diabetes, April 1, 2007; 56(4): 1010 - 1013. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Blouin, C. Richard, G. Brochu, F.-S. Hould, S. Lebel, S. Marceau, S. Biron, V. Luu-The, and A. Tchernof Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men J. Endocrinol., December 1, 2006; 191(3): 637 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Li, E. S. Ford, A. H. Mokdad, and S. Cook Recent Trends in Waist Circumference and Waist-Height Ratio Among US Children and Adolescents Pediatrics, November 1, 2006; 118(5): e1390 - e1398. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Bailey, J C. Loredo-Osti, P. Lepage, J. Faith, J. Fontaine, K. M. Desbiens, T. J. Hudson, C. Bouchard, D. Gaudet, L. Perusse, et al. Common Polymorphisms in the Promoter of the Visfatin Gene (PBEF1) Influence Plasma Insulin Levels in a French-Canadian Population. Diabetes, October 1, 2006; 55(10): 2896 - 2902. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tchernof, C. Belanger, A.-S. Morisset, C. Richard, J. Mailloux, P. Laberge, and P. Dupont Regional differences in adipose tissue metabolism in women: minor effect of obesity and body fat distribution. Diabetes, May 1, 2006; 55(5): 1353 - 1360. [Abstract] [Full Text] [PDF] |
||||
![]() |
C-J Tsai, M F Leitzmann, W C Willett, and E L Giovannucci Central adiposity, regional fat distribution, and the risk of cholecystectomy in women Gut, May 1, 2006; 55(5): 708 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Kreier, Y. S. Kap, T. C. Mettenleiter, C. van Heijningen, J. van der Vliet, A. Kalsbeek, H. P. Sauerwein, E. Fliers, J. A. Romijn, and R. M. Buijs Tracing from Fat Tissue, Liver, and Pancreas: A Neuroanatomical Framework for the Role of the Brain in Type 2 Diabetes Endocrinology, March 1, 2006; 147(3): 1140 - 1147. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Canoy, N. Wareham, A. Welch, S. Bingham, R. Luben, N. Day, and K.-T. Khaw Plasma ascorbic acid concentrations and fat distribution in 19 068 British men and women in the European Prospective Investigation into Cancer and Nutrition Norfolk cohort study Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1203 - 1209. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Despres, A. Golay, L. Sjostrom, and the Rimonabant in Obesity-Lipids Study Group Effects of Rimonabant on Metabolic Risk Factors in Overweight Patients with Dyslipidemia N. Engl. J. Med., November 17, 2005; 353(20): 2121 - 2134. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Punjabi and V. Y. Polotsky Disorders of glucose metabolism in sleep apnea J Appl Physiol, November 1, 2005; 99(5): 1998 - 2007. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Despres Our Passive Lifestyle, Our Toxic Diet, and the Atherogenic/Diabetogenic Metabolic Syndrome: Can We Afford to Be Sedentary and Unfit? Circulation, July 26, 2005; 112(4): 453 - 455. [Full Text] [PDF] |
||||
![]() |
J. L Kuk, S. Lee, S. B Heymsfield, and R. Ross Waist circumference and abdominal adipose tissue distribution: influence of age and sex Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1330 - 1334. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ferretti, T. Bacchetti, C. Moroni, S. Savino, A. Liuzzi, F. Balzola, and V. Bicchiega Paraoxonase Activity in High-Density Lipoproteins: A Comparison between Healthy and Obese Females J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1728 - 1733. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okazaki, S. Usui, M. Ishigami, N. Sakai, T. Nakamura, Y. Matsuzawa, and S. Yamashita Identification of Unique Lipoprotein Subclasses for Visceral Obesity by Component Analysis of Cholesterol Profile in High-Performance Liquid Chromatography Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): 578 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Chan, G. F. Watts, T. W.K. Ng, Y. Uchida, N. Sakai, S. Yamashita, and P. H. R. Barrett Adiponectin and other Adipocytokines as Predictors of Markers of Triglyceride-Rich Lipoprotein Metabolism Clin. Chem., March 1, 2005; 51(3): 578 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-T. Berthier, A. Houde, M. Cote, A.-M. Paradis, P. Mauriege, J. Bergeron, D. Gaudet, J.-P. Despres, and M.-C. Vohl Impact of adiponectin gene polymorphisms on plasma lipoprotein and adiponectin concentrations of viscerally obese men J. Lipid Res., February 1, 2005; 46(2): 237 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Miller, B. M. K. Biller, J. G. Lipman, G. Bradwin, N. Rifai, and A. Klibanski Truncal Adiposity, Relative Growth Hormone Deficiency, and Cardiovascular Risk J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 768 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Blanchette, K. Blouin, C. Richard, P. Dupont, V. Luu-The, and A. Tchernof Expression and Activity of 20{alpha}-Hydroxysteroid Dehydrogenase (AKR1C1) in Abdominal Subcutaneous and Omental Adipose Tissue in Women J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 264 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Hafidi, I. Perez, J. Zamora, V. Soto, G. Carvajal-Sandoval, and G. Banos Glycine intake decreases plasma free fatty acids, adipose cell size, and blood pressure in sucrose-fed rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1387 - R1393. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.C. Chan, G.F. Watts, P.H.R. Barrett, A.J. Whitfield, and F.M. van Bockxmeer ATP-Binding Cassette Transporter G8 Gene As a Determinant of Apolipoprotein B-100 Kinetics in Overweight Men Arterioscler. Thromb. Vasc. Biol., November 1, 2004; 24(11): 2188 - 2191. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. W. Aude, A. S. Agatston, F. Lopez-Jimenez, E. H. Lieberman, Marie Almon, M. Hansen, G. Rojas, G. A. Lamas, and C. H. Hennekens The National Cholesterol Education Program Diet vs a Diet Lower in Carbohydrates and Higher in Protein and Monounsaturated Fat: A Randomized Trial Arch Intern Med, October 25, 2004; 164(19): 2141 - 2146. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Bolduc, M Larose, M Yoshioka, P Ye, P Belleau, C Labrie, J Morissette, V Raymond, F Labrie, and J St-Amand Effects of dihydrotestosterone on adipose tissue measured by serial analysis of gene expression J. Mol. Endocrinol., October 1, 2004; 33(2): 429 - 444. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Schroeder, L. Zheng, M. D. Ong, C. Martinez, C. Flores, Y. Stewart, C. Azen, and F. R. Sattler Effects of Androgen Therapy on Adipose Tissue and Metabolism in Older Men J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4863 - 4872. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-J. Tsai, M. F Leitzmann, W. C Willett, and E. L Giovannucci Prospective study of abdominal adiposity and gallstone disease in US men Am. J. Clinical Nutrition, July 1, 2004; 80(1): 38 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Alvarez, T. P. Ballard, S. D. Beske, and K. P. Davy Subcutaneous obesity is not associated with sympathetic neural activation Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H414 - H418. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hayashi, E. J. Boyko, D. L. Leonetti, M. J. McNeely, L. Newell-Morris, S. E. Kahn, and W. Y. Fujimoto Visceral Adiposity Is an Independent Predictor of Incident Hypertension in Japanese Americans Ann Intern Med, June 15, 2004; 140(12): 992 - 1000. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Carr and J. D. Brunzell Abdominal Obesity and Dyslipidemia in the Metabolic Syndrome: Importance of Type 2 Diabetes and Familial Combined Hyperlipidemia in Coronary Artery Disease Risk J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2601 - 2607. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wergedahl, B. Liaset, O. A. Gudbrandsen, E. Lied, M. Espe, Z. Muna, S. Mork, and R. K. Berge Fish Protein Hydrolysate Reduces Plasma Total Cholesterol, Increases the Proportion of HDL Cholesterol, and Lowers Acyl-CoA:Cholesterol Acyltransferase Activity in Liver of Zucker Rats J. Nutr., June 1, 2004; 134(6): 1320 - 1327. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Lemieux Energy Partitioning in Gluteal-Femoral Fat: Does the Metabolic Fate of Triglycerides Affect Coronary Heart Disease Risk? Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 795 - 797. [Full Text] |
||||
![]() |
S. Alam, M. Stolinski, C. Pentecost, M. A. Boroujerdi, R. H. Jones, P. H. Sonksen, and A. M. Umpleby The Effect of a Six-Month Exercise Program on Very Low-Density Lipoprotein Apolipoprotein B Secretion in Type 2 Diabetes J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 688 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dabelea, G. Kinney, J. K. Snell-Bergeon, J. E. Hokanson, R. H. Eckel, J. Ehrlich, S. Garg, R. F. Hamman, and M. Rewers Effect of Type 1 Diabetes on the Gender Difference in Coronary Artery Calcification: a Role for Insulin Resistance?: The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study Diabetes, November 1, 2003; 52(11): 2833 - 2839. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K Fried and S. P Rao Sugars, hypertriglyceridemia, and cardiovascular disease Am. J. Clinical Nutrition, October 1, 2003; 78(4): 873S - 880. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Dorn, K. Hovey, P. Muti, J. L. Freudenheim, M. Russell, T. H. Nochajski, and M. Trevisan Alcohol Drinking Patterns Differentially Affect Central Adiposity as Measured by Abdominal Height in Women and Men J. Nutr., August 1, 2003; 133(8): 2655 - 2662. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Chiasson, R. G. Josse, R. Gomis, M. Hanefeld, A. Karasik, and M. Laakso Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose Tolerance: The STOP-NIDDM Trial JAMA, July 23, 2003; 290(4): 486 - 494. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-B. Nguyen-Duy, M. Z. Nichaman, T. S. Church, S. N. Blair, and R. Ross Visceral fat and liver fat are independent predictors of metabolic risk factors in men Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1065 - E1071. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hayashi, E. J. Boyko, D. L. Leonetti, M. J. McNeely, L. Newell-Morris, S. E. Kahn, and W. Y. Fujimoto Visceral Adiposity and the Risk of Impaired Glucose Tolerance: A prospective study among Japanese Americans Diabetes Care, March 1, 2003; 26(3): 650 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. De Michele, S. Panico, A. Iannuzzi, E. Celentano, A. V. Ciardullo, R. Galasso, L. Sacchetti, F. Zarrilli, M. G. Bond, and P. Rubba Association of Obesity and Central Fat Distribution With Carotid Artery Wall Thickening in Middle-Aged Women Stroke, December 1, 2002; 33(12): 2923 - 2928. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Y. Tong, Z. S. K. Lee, M.-M. Sea, C.-C. Chow, G. T. C. Ko, W.-B. Chan, W.-Y. So, R. C. W. Ma, R. Ozaki, J. Woo, et al. The Effect of Orlistat-Induced Weight Loss, Without Concomitant Hypocaloric Diet, on Cardiovascular Risk Factors and Insulin Sensitivity in Young Obese Chinese Subjects With or Without Type 2 Diabetes Arch Intern Med, November 25, 2002; 162(21): 2428 - 2435. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhu, Z. Wang, S. Heshka, M. Heo, M. S Faith, and S. B Heymsfield Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds Am. J. Clinical Nutrition, October 1, 2002; 76(4): 743 - 743. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Dewailly, C. Blanchet, S. Gingras, S. Lemieux, and B. J. Holub Cardiovascular disease risk factors and n-3 fatty acid status in the adult population of James Bay Cree Am. J. Clinical Nutrition, July 1, 2002; 76(1): 85 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Oppert, M.-A. Charles, N. Thibult, B. Guy-Grand, E. Eschwege, and P. Ducimetiere Anthropometric estimates of muscle and fat mass in relation to cardiac and cancer mortality in men: the Paris Prospective Study Am. J. Clinical Nutrition, June 1, 2002; 75(6): 1107 - 1113. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Janssen, S. B Heymsfield, D. B Allison, D. P Kotler, and R. Ross Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat Am. J. Clinical Nutrition, April 1, 2002; 75(4): 683 - 688. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. McTernan, L. A. Anderson, A. J. Anwar, M. C. Eggo, J. Crocker, A. H. Barnett, P. M. Stewart, and S. Kumar Glucocorticoid Regulation of P450 Aromatase Activity in Human Adipose Tissue: Gender and Site Differences J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1327 - 1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Greco, G. Mingrone, A. Giancaterini, M. Manco, M. Morroni, S. Cinti, M. Granzotto, R. Vettor, S. Camastra, and E. Ferrannini Insulin Resistance in Morbid Obesity: Reversal With Intramyocellular Fat Depletion Diabetes, January 1, 2002; 51(1): 144 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Dewailly, C. Blanchet, S. Gingras, S. Lemieux, L. Sauve, J. Bergeron, and B. J. Holub Relations between n-3 fatty acid status and cardiovascular disease risk factors among Quebecers Am. J. Clinical |